DANAHER CORPORATION (NYSE:DHR) Files An 8-K Other Events

18

DANAHER CORPORATION (NYSE:DHR) Files An 8-K Other Events

ITEM 8.01

OTHER EVENTS
Attached hereto are (1) audited consolidated balance sheets of
Danaher Corporation (the Company) and subsidiaries as of December
31, 2016 and 2015, and the related consolidated statements of
earnings, comprehensive income, stockholders equity and cash
flows for each of the three years in the period ended December
31, 2016 and (2) an unaudited consolidated balance sheet of the
Company and subsidiaries as of March 31, 2017, and the related
consolidated statements of earnings, comprehensive income,
stockholders equity and cash flows for each of three-month
periods ended March 31, 2017 and April 1, 2016.
The attached financial statements have been revised solely to
expressly acknowledge that the Company has guaranteed long-term
debt and commercial paper issued by certain of its subsidiaries,
including DH Europe Finance S.A. (Danaher International) and DH
Switzerland Finance S.A. (Danaher Switzerland), each of which is
a 50%-owned finance subsidiary, that all securities issued by
each of Danaher International and Danaher Switzerland are fully
and unconditionally guaranteed by the Company, and that these
guarantees rank on parity with the Companys unsecured and
unsubordinated indebtedness. The attached financial statements
are otherwise unchanged from the corresponding financial
statements previously filed by the Company with its Annual Report
on Form 10-K for the year ended December 31, 2016 and its
Quarterly Report on Form 10-Q for the period ended March 31,
2017, respectively.
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
(d)
Exhibits:
Exhibit No.
Description
23.1
Consent of Independent Registered Public Accounting
Firm
99.1
Audited consolidated balance sheets of the Company and
subsidiaries as of December 31, 2016 and 2015, and the
related consolidated statements of earnings,
comprehensive income, stockholders equity and cash
flows for each of the three years in the period ended
December 31, 2016
99.2
Unaudited consolidated balance sheet of the Company and
subsidiaries as of March 31, 2017, and the related
consolidated statements of earnings, comprehensive
income, stockholders equity and cash flows for each of
three-month periods ended March 31, 2017 and April 1,
2016.
101.INS
XBRL Instance Document *
101.SCH
XBRL Taxonomy Extension Schema Document *
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB
XBRL Taxonomy Extension Label Linkbase Document *
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
*
* Attached as Exhibit 101 to this report are the following
documents formatted in XBRL (Extensible Business Reporting
Language): (i) Consolidated Balance Sheets as of December 31,
2016 and 2015 and Consolidated Condensed Balance Sheets as of
March 31, 2017 and December 31, 2016, (ii) Consolidated
Statements of Earnings for the years ended December 31, 2016,
2015 and 2014 and Consolidated Condensed Statements of Earnings
for the three-month periods ended March 31, 2017 and April 1,
2016, (iii) Consolidated Statements of Comprehensive Income for
the years ended December 31, 2016, 2015 and 2014 and Consolidated
Condensed Statements of Comprehensive Income for the three-month
periods ended March 31, 2017 and April 1, 2016, (iv) Consolidated
Statement of Stockholders Equity for the years ended December 31,
2016, 2015 and 2014 and Consolidated Condensed Statement of
Stockholders Equity for the three-month period ended March 31,
2017, (v) Consolidated Statements of Cash Flows for the years
ended December 31, 2016, 2015 and 2014 and Consolidated Condensed
Statements of Cash Flows for the three-month periods ended March
31, 2017 and April 1, 2016, and (vi) Notes to the Consolidated
Financial Statements and the Consolidated Condensed Financial
Statements.


About DANAHER CORPORATION (NYSE:DHR)

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world’s food supply, improve packaging design and quality, and verify pharmaceutical dosages.

An ad to help with our costs